Biosensors Surges Close To $1 On DBSV Report

Today saw Biosensors International Group chalk up crazy gains after DBS Vickers issued a positive report. The stock re-entered the top volume with shares changing hands furiously. Report summary follows.


BIG returns from stent
DBSV
16 Sep 2010

• BioMatrix, its leading product, is the first biodegradable polymer drug eluting stent in the world with a global market share of 1.3%.

• Earnings will continue to soar on market share gains, after a solid turnaround in FY10.

• Potential earnings upside on securing approvals for BioMatrix’s sale in new markets - Japan and China, with a combined market size of US$800m – US$1bn.

• A prime target for take-over, coupled with upcoming MicroPort’s HK IPO, serves as re-rating catalyst

• Initiate with BUY, TP of S$1.20, a 43% upside